FDA PMA Approvals
Premarket Approval devices tracked by MedTracker
PMA
2026-02-18
PMA
2026-02-18
Fluorescence in situ hybridization, anaplastic lymphoma kinase, gene rearrangement
View Details →
PMA
2026-02-18
Fluorescence in situ hybridization, chromosome 17p deletion (TP53)
View Details →
PMA
2026-02-18
Vagus nerve stimulator for rheumatoid arthritis
View Details →
PMA
2026-02-17
Daily wear soft contact lens to reduce the progression of myopia
View Details →
PMA
2026-02-12
replacement Heart-valve
View Details →
PMA
2026-02-12
heart-valve, non-allograft tissue
View Details →
PMA
2026-02-12
Device, thermal ablation, endometrial
View Details →
PMA
2026-02-12
Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions
View Details →
PMA
2026-02-11
Device, incontinence, mechanical/hydraulic
View Details →
PMA
2026-02-10
Drug eluting permanent left ventricular (lv) pacemaker electrode
View Details →
PMA
2026-02-10
Lens, contact, orthokeratology, overnight
View Details →No matching devices.
Page 40 of 80